Respiratory medicine


Improving the management of chronic asthma in children

21 Dec 2020Registered users

There is no gold standard test to diagnose asthma. As a result, overdiagnosis and underdiagnosis are common especially when relying on history and clinical examination alone. Spirometry and bronchodilator reversibility testing are particularly useful when a child aged 5 years or older is brought to the practice with symptoms. The validated Asthma Control Test for children aged 12 years and over and the Children’s Asthma Control Test for children aged 4-11 years should be used to assess current asthma control based on four-week recall. Asthma control test scores correlate poorly with lung function and measures of airway inflammation such as FeNO in children and should not be used in isolation.

Diagnosis and management of malignant pleural mesothelioma

21 Dec 2020

Mesothelioma accounts for less than 1% of all cancers in England, Wales and Northern Ireland. There are almost 2,500 new diagnoses a year, of which 96% are pleural. The median age at diagnosis for malignant pleural mesothelioma (MPM) is 76 years. The majority of cases occur in men, most commonly following occupational exposure to asbestos. There is a latent period, usually 30-40 years, between exposure and disease development. A chest X-ray is usually the first-line investigation; 94% of patients with MPM have a unilateral pleural effusion, although the chest X-ray may be normal or show another asbestos-related lung disease. 

Improving COPD outcomes in primary care

24 Oct 2019Paid-up subscribers

Diagnosis of COPD is based on the presence of airflow obstruction after the administration of a bronchodilator i.e. post-bronchodilator spirometry. However, the National COPD Audit report for 2017-18 found that 59.5% of people hospitalised with a COPD exacerbation in England and Wales had no spirometry result available and in 12% of those who had undergone spirometry the test showed no airflow obstruction. Patients with COPD should be reviewed annually. It is advisable to repeat spirometry if there is a significant change in symptoms. It is important to determine objective measures of breathlessness (MRC dyspnoea score), quality of life (CAT questionnaire) and exacerbations (annual exacerbation and hospitalisation rate) as part of this review.

Detecting obstructive sleep apnoea hypopnoea syndrome

24 Oct 2019Paid-up subscribers

Obstructive sleep apnoea hypopnoea syndrome (OSAHS) is characterised by repeated episodes of partial or complete collapse of the upper respiratory passages, mainly the oropharyngeal tract, during sleep. Obesity is the strongest risk factor for OSAHS; other risk factors include smoking, excessive drinking, sedatives and hypnotics. Habitual snoring, unrefreshing sleep and daytime somnolence suggests the possibility of OSAHS. When this is combined with a partner’s account of nocturnal apnoeas or snoring pauses the diagnosis becomes highly likely. However, negative screening results or the absence of clinical features by themselves should not be used to rule out OSAHS.

Managing complications of cystic fibrosis in adults

22 Nov 2018Registered users

Overall survival has improved dramatically for patients with cystic fibrosis (CF) since the millennium such that median life expectancy now extends into the fifth decade. However, with increasing longevity comes a range of comorbidities, some as complications of the disease itself but others as a consequence of long-term treatments required to manage CF. Chronic infection and inflammation eventually cause irreversible bronchiectasis and decline in pulmonary function, and 90% of CF deaths are caused by progressive respiratory failure.

Managing mild to moderate asthma in adults

22 Nov 2018Registered users

The National Review of Asthma Deaths found that most patients who died were actually considered to have mild to moderate asthma, with 57% of fatal cases not under specialist care at the time of their death. In cases of fatal asthma there was widespread underuse of inhaled corticosteroids and an overreliance on short-acting beta-agonists. Referral to secondary care should take place when there is diagnostic uncertainty or atypical features, the possibility of hypersensitivity to inhaled material or concerns over treatment or exacerbations. Patients who have suffered even a single life-threatening asthma attack should be under specialist supervision. 

Diagnosing and managing cystic fibrosis in children

22 Nov 2018Registered users

Cystic fibrosis (CF) is a multisystem genetic disorder affecting around 1 in 2,500 live births in the UK. Although all newborns undergo screening for CF, around 15% of infants will present shortly after birth with meconium ileus and some will already have faltering growth when the screening results are available at 3-4 weeks of age. Infants who present with meconium ileus should be treated with a high index of suspicion for CF until proven otherwise. Mucociliary dysfunction leads to accumulation of mucus in the airways and secondary infection. Respiratory symptoms may be non-specific initially and include cough and wheeziness, frequent respiratory infections and, in older children, sinusitis.

Improving outcomes in COPD

23 Nov 2017Registered users

Cigarette smoking is overwhelmingly the most important risk factor for COPD. In some cases, other factors such as occupation, passive exposure to inhalants and fetal nutrition/low birthweight are also important. The diagnosis should be suspected in symptomatic patients with risk factors, usually cigarette smoking, aged 40 years or above, albeit a majority of people with COPD present when considerably older. The 2017 GOLD guideline recommends that management should be focused on two objectives. First, to relieve symptoms of breathlessness (assessed using the MRC dyspnoea scale) and improve quality of life (assessed by the COPD Assessment Test). Second, to reduce risk assessed by the number of exacerbations and hospitalisations in the previous year.

Regular review pivotal in chronic asthma in children

23 Nov 2017Paid-up subscribers

The aim of asthma treatment is complete control of symptoms as soon as possible while minimising side effects and inconvenience to the patient. All parents and older children should be offered a written action plan. This should include details of the patient’s regular medicines, how to recognise deterioration and what to do in the event of an attack. Children should be referred to secondary care if: the diagnosis is unclear; control remains poor despite monitored treatment; they have suffered a life-threatening attack or red flag features are present.

GPs have key role in improving outcomes in acute asthma

24 Nov 2016Registered users

Features which indicate a high risk of severe attacks include: previous admission to intensive care, particularly if requiring mechanical ventilation; previous admission with asthma especially in the past year or repeated emergency admissions; history of worsening asthma in January or February; use of three or more classes of asthma medication; heavy use of beta-2 agonists; anxiety traits; and marital stress. 

Assessment and management of active and latent TB

24 Nov 2016Paid-up subscribers

Clinically significant disease occurs through progression of primary infection or through later reactivation of latent TB infection (LTBI); this is most likely to occur in the first few years following infection, although late reactivation can occur several decades later, particularly in individuals who become immunosuppressed. Risk of TB acquisition is increased in people who have come to the UK from high incidence countries or who are born in the UK but come from high-risk ethnic minority groups. Other risk groups include those who are homeless, in prison or who misuse drugs or alcohol.

Optimising the management of patients with difficult asthma

25 Nov 2015Registered users

Between 5 and 10% of asthma (depending on the definition used) is categorised as difficult asthma, a term which generally refers to patients who continue to experience symptoms and frequent exacerbations despite the prescription of high-dose asthma therapy. Difficult asthma is an indication for specialist review by an appropriate respiratory physician, but close liaison between primary, secondary and tertiary care is critical.

Improving the diagnosis and management of COPD

25 Nov 2015Paid-up subscribers

COPD is a progressive condition. Therefore, earlier diagnosis allows earlier intervention in particular smoking cessation. Spirometry should be performed in symptomatic current or former smokers (typically ≥ 10 pack years) who are aged at least 35 where COPD is a likely differential diagnosis.

This article online comes with updates and links to recent research and guidance, most notably the GOLD 2017 guide to COPD.

Improving the management of asthma in adults in primary care

24 Nov 2014

Studies in adult patients have suggested that 30% of those diagnosed with asthma do not have the condition and it is likely that the diagnosis is missed in many others. The BTS/SIGN guideline advocates spirometry after taking the history. If airflow obstruction is present, a trial of treatment can commence, but a firm diagnosis also requires a symptomatic response and an improvement in the measured airflow obstruction. The FeNO level correlates well with airway inflammation, and is therefore a good indicator of asthma and in particular of the likely response to inhaled corticosteroids. The test is especially useful for patients with suggestive symptoms but normal spirometry.

Early diagnosis pivotal to survival in lung cancer

24 Nov 2014Paid-up subscribers

Lung cancer is the most common cause of cancer death, both in the UK and worldwide. There has been little change in survival over the past 20 years, with increasing evidence that there are disparities in outcomes between the UK and other comparable healthcare systems. It has been postulated that this is due to an excess of early deaths, delays in diagnosis are thought to contribute to this problem. A recent study showed that 30% of patients with lung cancer die within the first 90 days and they have seen their GP on average five times in the four months before diagnosis, suggesting there may be opportunities to diagnose these patients earlier in the disease process. The challenge GPs face is to identify and refer those at risk as early as possible and to maintain a high index of suspicion if symptoms persist.  [With external links to current evidence base]

Diagnosing and managing pulmonary hypertension

12 Dec 2012Paid-up subscribers

Pulmonary hypertension (PH) is defined as an increase in mean pulmonary arterial pressure ≥ 25 mmHg at rest as assessed invasively by right heart catheterisation. It can affect patients at any age and presents with non-specific symptoms. Accurate diagnosis is important as while PH is a potentially lethal disease it is treatable. Identification of the cause of PH is crucial to ensure that the patient receives appropriate management.

Occupational asthma often goes unrecognised

12 Dec 2012

Occupational asthma is induced de novo by an airborne agent encountered in the workplace. The risk of occupational asthma is greater in those with a prior atopic history. Work-exacerbated asthma is the provocation of pre-existing, or coincidental, disease by one or more irritant exposures at work. Distinguishing occupational from work-exacerbated asthma can be difficult but it is important since the two have very different clinical, occupational and legal implications. 

Improving outcomes in lung cancer patients

23 Nov 2011Registered users

Lung cancer is the leading cause of cancer mortality in the UK resulting in more than 33,500 deaths in 2008, 4,000 more than for bowel and breast cancer combined. Five-year survival figures are poor but have recently improved from around 5% to 7.5% in men and 8.5% in women.There is evidence of marked variation in the standard of care in England.  It has recently been shown that if patients are first referred to a thoracic surgical centre, rather than a hospital that does not have thoracic surgeons on site, they are 51% more likely to have a resection. There are similar findings for other active treatments. By reducing this variation there is scope for marked improvement in outcomes, possibly to levels seen in other countries such as Australia, Canada, Sweden and Norway where five-year survival rates are approximately double. Thus there is a need to encourage lung cancer teams to select patients correctly so that the best treatment can be offered. Improving diagnosis, staging and fitness assessment was a major focus in the recently updated NICE guideline on diagnosis and treatment of lung cancer, published in April 2011.  [With external links to current evidence and summaries]

New tests will improve detection of latent TB

22 Nov 2011Paid-up subscribers

In the UK, after a century of declining incidence, over the past 20 years numbers of cases of active TB have increased substantially. This increase has occurred almost exclusively in individuals born outside the UK. GPs represent the first point of contact with health services for most patients, and it is crucial that GPs are aware of the clinical features of active TB, and that diagnosis can frequently be made using simple and inexpensive tests such as chest X-rays and sputum samples. There is a major focusin the UK on raising awareness of TB in frontline medical staff, through the activities of bodies such as the charity TB Alert, and the Department of Health’s National Knowledge Service TB Project At a local level, information and advice can readily be obtained through the local TB nursing service.

Opportunistic case finding pivotal in diagnosing COPD

23 Nov 2010Paid-up subscribers

Diagnosis, management and delivery of care for patients with chronic obstructive pulmonary disease (COPD) remains an important issue for clinicians. COPD accounts for more than 10% of emergency hospital admissions. The 2008 National COPD Audit showed that the 90-day mortality rate after a COPD hospitalisation was 13.9% and almost one in three patients discharged from hospital were readmitted within three months. Over the past decade a huge number of publications have strengthened the evidence base which is the foundation for COPD management while the development of a National Clinical Strategy for COPD and the 2010 update to the NICE COPD guidelines should help implementation of an evidence-based approach to management. At the time of writing (November 2010) the consultation phase of the National Clinical Strategy had been completed but no publication date had been set.

Tackling upper respiratory tract infections

22 Nov 2010Paid-up subscribers

Upper respiratory tract infection (URTI) refers to a wide range of acute illnesses that affect the upper respiratory tract. URTIs are the most common reason for general practice consultations. On average adults suffer two to three such infections per year. Most URTIs are self-managed. A UK study of 516 women aged 20-44 years found that only one in 18 episodes of sore throat led to a general practice consultation. Patients who do seek consultations often benefit from reassurance, education and instructions for symptomatic home treatment. A large proportion of antibiotic prescribing in primary care is for respiratory tract infections. There was a 44% reduction in antibiotic prescribing for respiratory tract infections between 1994 and 2000. The larger part of this reduction was due to lower consultation rates rather than a decrease in prescribing by GPs. Antibiotics are frequently prescribed for resolving symptoms and to prevent complications. Patients' expectations have a significant influence on prescribing, even when their doctor judges that antibiotics are not indicated.There are certain at-risk groups who require immediate antibiotics or further evaluation.

Managing LRTI in adults in the community

15 Nov 2009Registered users

Lower respiratory tract infection (LRTI) is a common cause of consultation in primary care. In 2004, approximately 5% of the population consulted their GP about LRTI at least once during the year, a rate comparable with those reported by previous UK studies.

Obstructive sleep apnoea increases risk of CVD

15 Nov 2009Paid-up subscribers

In OSA, the patient suffers repeated episodes of apnoea caused by narrowing or closure of the pharyngeal airway during sleep. About 2-4% of the middle-aged population have OSA. Although understanding of the condition has improved considerably, it is estimated that 85-90% of sufferers still remain undiagnosed.

Reducing exacerbations in patients with COPD

19 Nov 2008Paid-up subscribers

More than 27,000 people die from chronic obstructive pulmonary disease (COPD) each year in the UK. It is estimated that there are around 1.5 million adults with COPD, thus a GP practice with approximately 7,000 patients will have up to 200 patients with COPD on its practice list.


Managing patients with difficult asthma

19 Nov 2008Paid-up subscribers

Asthma affects around 5.2 million people in the UK. There are more than 4.1 million GP consultations for asthma each year and every GP will see patients with respiratory symptoms who may have asthma, or have been diagnosed with asthma but continue to have ongoing problems.  Approximately 1,400 patients with asthma die each year in the UK, which equates to around one death every seven hours. Confidential enquiries into asthma deaths have repeatedly shown that patients and relatives often fail to appreciate the severity of symptoms, while clinical staff may fail to assess severity by objective measurements. Underuse of iv or oral steroids is also a common factor.

Have a high index of suspicion for TB

01 Nov 2007Paid-up subscribers

The prevalence of tuberculosis (TB) has increased dramatically around the world over the past decade.With population mobility on a scale never seen before, major cities in the UK and other relatively prosperous countries are reflecting the trends of disease in the wider world. In addition, there has been an increase in TB in some groups within the UK population and an increase in the dispersal of immigrants and asylum seekers to parts of the country that historically have had little experience of such populations. As a consequence, most GPs, wherever they practise, are more likely to see a case of TB in the next year than at any time in their past career. Nearly 8,200 cases of TB were reported in England, Northern Ireland and Wales in 2006. London accounted for the highest proportion of cases (42%) and the Midlands the second highest (12%). In 2005, TB was responsible for 357 deaths in the UK.

New developments in the treatment of asthma

01 Nov 2007Paid-up subscribers

Around 100 million people in Europe and North America have asthma,1,2 equating to 6% of adults and 10% of children. In the UK, approximately 5.2 million patients (1.1 million children and 4.1 million adults) are currently receiving treatment for asthma and eight million have been diagnosed with asthma at some stage in their lives. The UK currently has the highest frequency of self-reported asthma symptoms among children aged 13-14 years in the world.

Managing adults with cystic fibrosis

01 Nov 2007Paid-up subscribers

Cystic fibrosis (CF) is becoming a chronic disease of adults rather than a fatal disease of childhood. One in 2,500 newborn babies are affected by CF, giving a UK population of around 7,000 patients. Median survival is currently 34 years but has been increasing every year, with recent data suggesting that someone born with CF in 2000 can be expected to live into their fifties or sixties.